Oral Lactulose – A Safe and Effective Strategy for the Management of Constipation in Individuals with Impaired Glucose Tolerance and Diabetes

Valentin Faerber1*, Katharina Stefanie Kuhn2, Eva Svehlikova3, Angelika Kuchinka-Koch4, Thomas R Pieber3 1Department of Medical, Clinical & Regulatory Affairs, Business Unit Parenteral Nutrition, Keto-Analogues and Standard I.V. Fluids, Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany 2Medical Writing, Stuttgart, Germany 3Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria 4Market Unit Lactulose, Fresenius Kabi Austria GmbH, Linz, Austria *Correspondence should be addressed to Valentin Faerber; Valentin.faerber@fresenius-kabi.com